ICAD iCAD Accounting Capitalization
The stock price retrospective for iCAD, Inc. (ICAD) demonstrates the dynamics of an asset with a market valuation currently at 0.03. The US vendor develops AI-based software solutions for neoplasm detection and radiotherapy equipment. Diagnostic efficiency is enhanced by integrating ProFound AI algorithms into hardware from third-party scanner manufacturers. The seamless distribution of equipment is ensured by an extensive warehouse network and reliable agreements with counterparties.
Financial and market metric breakdowns for iCAD Corp (ICAD)
The high precision of iCAD, Inc. (ICAD) AI algorithms in oncology diagnostics enables the company to apply premium pricing to its software, directly increasing the value of its net assets. This metric measures the difference between all assets and liabilities, capturing the real book value of the business, which allows investors to assess the company's internal stability through its history of accounting capitalization.